$AEMD "We are extremely pleased that our initial s
Post# of 26709
Posted On: 02/25/2016 9:43:25 AM
$AEMD "We are extremely pleased that our initial study data has been published and we appreciate forthcoming opportunities to further advance our TauSome™ biomarker as a non-invasive solution to detect and monitor CTE in living individuals," stated Jim Joyce, Founder of Exosome Sciences and Chairman and CEO of Aethlon Medical.
#CTE
http://stockpumpers.blogspot.com/2016/02/aeth...ences.html
#CTE
http://stockpumpers.blogspot.com/2016/02/aeth...ences.html
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼